Reliance Pharma Fund - Direct Plan
The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.
Suitability
This product is suitable for investors who are seeking
• Long term capital growth.
• Investment in equity and equity related securities of pharma and other associated companies.
Fund Info
| Scheme Class | Equity |
| Scheme Category | Sector - Healthcare |
| Benchmark Type | S&P BSE Healthcare |
| Expense Ratio | 1.23% |
| Min subscription | ₹ 5,000 |
| Scheme Type | Open-ended |
| Scheme AUM (in Crs.) | ₹ 2,688 |
| AMC AUM (in Crs.) | ₹ 2,33,617 |
| Min Addition Subscription | ₹ 1,000 |
Performance
Comparison
Portfolio
AMC Details
Building Graph
Peer Comparison
| Fund | Min SIP Inv. | Min Inv. | Returns 3Y |
|---|---|---|---|
| 1000 | 1000 | -6.87% | |
| 1000 | 1000 | -6.87% | |
| 1000 | 1000 | 1.94% | |
| 1000 | 1000 | -4.0% | |
| 1000 | 1000 | 1.94% | |
| 1000 | 1000 | -4.0% | |
| 1000 | 1000 | 12.02% | |
| 500 | 500 | 9.28% | |
| 1000 | 1000 | 12.69% | |
| 1000 | 1000 | 9.17% | |
| 1000 | 1000 | 8.19% | |
| 1000 | 1000 | 12.0% | |
| 1000 | 1000 | 12.78% | |
| 1000 | 1000 | 10.24% |
Top 10 Holdings
| Company | Holding Type | Asset(%) |
|---|---|---|
| Sun Pharmaceuticals Industries Ltd | Equity | 12 |
| Divi's Laboratories Ltd | Equity | 11 |
| Aurobindo Pharma Ltd | Equity | 10 |
| Cipla Ltd | Equity | 9 |
| Dr Reddy's Laboratories Ltd | Equity | 7 |
| Syngene International Ltd | Equity | 7 |
| Biocon Ltd | Equity | 6 |
| Sanofi India Ltd | Equity | 6 |
| Lupin Ltd | Equity | 6 |
| Abbott India Ltd | Equity | 5 |
Asset Allocation(%)
| Asset | Percent |
|---|---|
| Equity | 99 |
| Other Assets And Liabilities | 0 |
| Cash | 0 |
| Cash - Repurchase Agreement | 0 |
Sector Allocation(%)
| Sector | Percent |
|---|---|
| Drug Manufacturers - Specialty & Generic | 54 |
| Drug Manufacturers - Major | 21 |
| Biotechnology | 13 |
| Medical Care | 6 |
| Diagnostics & Research | 4 |
Reliance Mutual Fund
AUM
₹2,33,617 Cr
About
Reliance Mutual Fund is a part of Reliance Anil Dhirubhai Ambani (ADA) Group and it is one of the largest growing asset management companies in India. It has an asset under management of Rs 2,40,445.37 and 83.99 lakhs folios.##Reliance Mutual Fund is present across 160 cities across the country. The main motto of the asset management company is to launch products that are not only innovative, but also conducive for investors. They believe in increasing their value to investors.##RMF provides a host of mutual funds across various categories, be it equity, debt and hybrid. The schemes have a well-managed portfolio and it has pioneered to become one of the most trusted asset management companies in India.##Reliance Mutual Fund has been sponsored by Reliance Capital Limited and Nippon Life Insurance Company.
Email
customer_care@reliancemutual.com
Phone
18002090007
Address
9th Floor, Crescenzo, C-38 & 39,,G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400051, Mumbai - 400055
Reliance Mutual Fund
Calculate Returns
LUMPSUM
SIP
Investment Amount
₹10,000
Return Amount
₹4,185
Return Rate
6%
Duration
6y 0m
Quick Links